ALOX5 and airway hyperresponsiveness: Accordingly, 1 μM WRW4 abolished the beneficial effects of RvD2 on TNF-α-induced activation of the 5-LOX/CysLTR1 pathway as well as TNF-α-induced airway hyperresponsiveness.